Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/04/195   
Active ingredient: 2-Methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]-phenol
Indication: Treatment of anaplastic thyroid cancer
Sponsor: Diamond BioPharm Limited
No 4 East Wing Gemini House, Flex Meadow, Harlow, Essex CM19 5TJ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/04/2004 Centralised Orphan - Designation EMEA/OD/072/03 (2004)1473 of 14/04/2004
01/02/2013 Centralised Orphan - Transfer of orphan designation EMA/OD/072/03/T/01 (2013)596 of 30/01/2013